|
PPA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28709998215015E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.28569999594086E-08 |
| Normal-vs-Stage2 |
1.962240E-03 |
| Normal-vs-Stage3 |
3.75120000000173E-05 |
| Normal-vs-Stage4 |
1.548340E-02 |
| Stage1-vs-Stage2 |
8.796600E-01 |
| Stage1-vs-Stage3 |
1.093560E-01 |
| Stage1-vs-Stage4 |
2.669000E-01 |
| Stage2-vs-Stage3 |
2.560400E-01 |
| Stage2-vs-Stage4 |
3.549200E-01 |
| Stage3-vs-Stage4 |
9.739000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.50069998042335E-09 |
| Normal-vs-AfricanAmerican |
2.13279999999871E-05 |
| Normal-vs-Asian |
2.461400E-01 |
| Caucasian-vs-AfricanAmerican |
5.522000E-01 |
| Caucasian-vs-Asian |
8.263200E-01 |
| AfricanAmerican-vs-Asian |
7.497400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21169996258885E-09 |
| Normal-vs-Female |
6.50840000004926E-07 |
| Male-vs-Female |
7.635400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.50349999999256E-05 |
| Normal-vs-Extreme_Weight |
1.21959999987986E-07 |
| Normal-vs-Obese |
7.30539999604929E-08 |
| Normal-vs-Extreme_Obese |
5.437000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.725600E-01 |
| Normal_Weight-vs-Obese |
6.814800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.482210E-01 |
| Extreme_Weight-vs-Obese |
6.450600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.945700E-02 |
| Obese-vs-Extreme_Obese |
5.908400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.779900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.83419962446396E-10 |
| Normal-vs-Age(61-80Yrs) |
2.49139999963788E-07 |
| Normal-vs-Age(81-100Yrs) |
1.118070E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.749000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.400990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.114000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.678100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.110200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.194400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.40929998174266E-09 |
| Normal-VS-Type2 PRCC |
1.181270E-04 |
| Normal-VS-KIRP CIMP |
2.30959995572988E-09 |
| Normal-VS-Unclassified PRCC |
1.10899999961056E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.057600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.379750E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.936600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.163270E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.172200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.801700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66030000003925E-06 |
| Normal-vs-N1 |
5.03629999926147E-08 |
| Normal-vs-N2 |
3.24679999996746E-06 |
| N0-vs-N1 |
5.205700E-02 |
| N0-vs-N2 |
1.933840E-01 |
| N1-vs-N2 |
6.574600E-01 |
|
|
